BFS Form 4: Director Disposes 16,915 Shares, Receives 627.55 Phantom Shares
Rhea-AI Filing Summary
Clancy George Patrick Jr., a director of Saul Centers, Inc. (BFS), reported a sale of 16,915 shares of the issuer's common stock on 10/01/2025. The filing also records multiple outstanding director stock options (each for 2,500 shares across grant years 2016–2023) and a grant of 627.55 phantom shares on 10/01/2025 under the company’s Deferred Compensation Plan tied to the 2024 Stock Incentive Plan. The phantom-share entry shows a conversion reference price of $31.87 and reports 6,610.054 shares as the number of shares beneficially owned following reported derivative transactions, which includes 110.643 shares credited as dividend reinvestments on 7/31/2025. The form is a Section 16 disclosure of changes in beneficial ownership and director compensation; it documents a director sale plus continued equity-linked compensation and deferred/phantom holdings.
Positive
- Director compensation provided in equity-linked form via phantom shares under the company’s Deferred Compensation Plan, aligning director incentives with shareholder value
- Dividend reinvestment into phantom shares (110.643 shares on 7/31/2025) increased the director’s deferred equity holdings
Negative
- Director sale of 16,915 common shares on 10/01/2025 reduced direct insider ownership
- Significant outstanding option tranches (multiple 2,500-share grants) could lead to future dilution if exercised
Insights
TL;DR: Director sale of 16,915 shares with ongoing option and phantom-share holdings; appears to be routine director compensation and disposition.
The Form 4 discloses a direct disposition of 16,915 common shares by Director Clancy on 10/01/2025, alongside multiple outstanding director options (2,500-share tranches from 2016–2023) and a 10/01/2025 grant of 627.55 phantom shares under the Deferred Compensation Plan. The report explicitly notes a conversion reference price of $31.87 and shows 6,610.054 shares reported after derivatives activity, including dividend reinvestment of 110.643 phantom-share-based shares credited 7/31/2025. For investors, this filing documents insider liquidity and continued equity-linked compensation rather than an operational or financial event affecting company fundamentals.
TL;DR: Routine Section 16 disclosure showing director compensation in phantom shares and a personal stock disposition; governance norms appear followed.
The filing details standard governance activity: annual director stock options remain outstanding and the issuer granted phantom shares under its amended Deferred Compensation Plan. The inclusion of dividend reinvestment into phantom holdings is explicitly reported. The sale of 16,915 shares is documented with a Power of Attorney signature, indicating procedural compliance. There is no explicit statement of insider trading policy violation or extraordinary transaction; the filing is consistent with normal director compensation and disclosure practices.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock | 627.55 | $31.87 | $20K |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan. The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement. Includes 110.643 shares awarded July 31, 2025 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.
